Matches in SemOpenAlex for { <https://semopenalex.org/work/W1608484788> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W1608484788 endingPage "888" @default.
- W1608484788 startingPage "886" @default.
- W1608484788 abstract "Funding sources: none. Conflicts of interest: none declared. Madam, The PHACE syndrome is an uncommon condition seen in a subgroup of children, particularly associated with large segmental facial haemangiomas. It is an acronym coined by Frieden et al.1 for the association of Posterior fossa defects, Haemangiomas, Arterial anomalies, Cardiac defects and Coarctation of the aorta, and Eye anomalies. The ‘S’ in PHACES syndrome signifies associated Sternal clefting and/or Supraumbilical raphe. The haemangiomas associated with PHACE syndrome are typically large, prone to ulceration, and generally require treatment. Traditional treatment options for haemangiomas include observation, systemic and intralesional corticosteroids, interferon alfa‐2a, vascular lasers, sclerotherapy, embolization, immunomodulators and surgery.2 3–4 The first use of a beta blocker, oral propranolol, for infantile haemangiomas was reported in 2008.5 However, systemic propranolol carries a risk of serious adverse effects including bradycardia, arrhythmias, hypotension and hypoglycaemia.6 Children with PHACES syndrome may have cerebrovascular anomalies and oral propranolol can be a contraindication in these patients owing to the risk of cerebral ischaemia.6 The use of another beta blocker, topical timolol, was reported in the treatment of a thin eyelid haemangioma.7 To the best of our knowledge, this therapy has not been previously reported in the treatment of a large ulcerating haemangioma with PHACE syndrome." @default.
- W1608484788 created "2016-06-24" @default.
- W1608484788 creator A5003465151 @default.
- W1608484788 creator A5027517694 @default.
- W1608484788 date "2011-04-01" @default.
- W1608484788 modified "2023-10-18" @default.
- W1608484788 title "Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome" @default.
- W1608484788 cites W1645271935 @default.
- W1608484788 cites W1963910752 @default.
- W1608484788 cites W1965104570 @default.
- W1608484788 cites W2000217470 @default.
- W1608484788 cites W2002386165 @default.
- W1608484788 cites W2032525803 @default.
- W1608484788 cites W2049560629 @default.
- W1608484788 cites W2055089681 @default.
- W1608484788 cites W2083538022 @default.
- W1608484788 cites W2104143740 @default.
- W1608484788 cites W2270199190 @default.
- W1608484788 cites W4249339290 @default.
- W1608484788 doi "https://doi.org/10.1111/j.1365-2133.2010.10177.x" @default.
- W1608484788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21158749" @default.
- W1608484788 hasPublicationYear "2011" @default.
- W1608484788 type Work @default.
- W1608484788 sameAs 1608484788 @default.
- W1608484788 citedByCount "58" @default.
- W1608484788 countsByYear W16084847882012 @default.
- W1608484788 countsByYear W16084847882013 @default.
- W1608484788 countsByYear W16084847882014 @default.
- W1608484788 countsByYear W16084847882015 @default.
- W1608484788 countsByYear W16084847882016 @default.
- W1608484788 countsByYear W16084847882017 @default.
- W1608484788 countsByYear W16084847882018 @default.
- W1608484788 countsByYear W16084847882020 @default.
- W1608484788 countsByYear W16084847882021 @default.
- W1608484788 countsByYear W16084847882022 @default.
- W1608484788 crossrefType "journal-article" @default.
- W1608484788 hasAuthorship W1608484788A5003465151 @default.
- W1608484788 hasAuthorship W1608484788A5027517694 @default.
- W1608484788 hasConcept C141071460 @default.
- W1608484788 hasConcept C16005928 @default.
- W1608484788 hasConcept C2776035437 @default.
- W1608484788 hasConcept C2776467465 @default.
- W1608484788 hasConcept C2778073030 @default.
- W1608484788 hasConcept C2778151854 @default.
- W1608484788 hasConcept C2779980429 @default.
- W1608484788 hasConcept C2781092963 @default.
- W1608484788 hasConcept C2781302119 @default.
- W1608484788 hasConcept C42219234 @default.
- W1608484788 hasConcept C71924100 @default.
- W1608484788 hasConceptScore W1608484788C141071460 @default.
- W1608484788 hasConceptScore W1608484788C16005928 @default.
- W1608484788 hasConceptScore W1608484788C2776035437 @default.
- W1608484788 hasConceptScore W1608484788C2776467465 @default.
- W1608484788 hasConceptScore W1608484788C2778073030 @default.
- W1608484788 hasConceptScore W1608484788C2778151854 @default.
- W1608484788 hasConceptScore W1608484788C2779980429 @default.
- W1608484788 hasConceptScore W1608484788C2781092963 @default.
- W1608484788 hasConceptScore W1608484788C2781302119 @default.
- W1608484788 hasConceptScore W1608484788C42219234 @default.
- W1608484788 hasConceptScore W1608484788C71924100 @default.
- W1608484788 hasIssue "4" @default.
- W1608484788 hasLocation W16084847881 @default.
- W1608484788 hasLocation W16084847882 @default.
- W1608484788 hasOpenAccess W1608484788 @default.
- W1608484788 hasPrimaryLocation W16084847881 @default.
- W1608484788 hasRelatedWork W136125736 @default.
- W1608484788 hasRelatedWork W1976813408 @default.
- W1608484788 hasRelatedWork W2071323562 @default.
- W1608484788 hasRelatedWork W2081468611 @default.
- W1608484788 hasRelatedWork W2111619174 @default.
- W1608484788 hasRelatedWork W2382802091 @default.
- W1608484788 hasRelatedWork W2416875920 @default.
- W1608484788 hasRelatedWork W2940363019 @default.
- W1608484788 hasRelatedWork W3030044343 @default.
- W1608484788 hasRelatedWork W3143345267 @default.
- W1608484788 hasVolume "164" @default.
- W1608484788 isParatext "false" @default.
- W1608484788 isRetracted "false" @default.
- W1608484788 magId "1608484788" @default.
- W1608484788 workType "article" @default.